In vivo therapeutic synergy of SAR650984, a humanized anti-CD38 antibody, in combination with melphalan in a multiple myeloma xenograft.

被引：0
作者：
Lejeune, Pascale
Blanc, Veronique
Courta, Jacqueline
Egile, Coumaran
Vrignaud, Patricia
Deckert, Jutta
Park, Peter
Bissery, Marie-Christine
机构：
[1] Sanofi Aventis, Vitry Sur Seine, France
[2] ImmunoGen Inc, Waltham, MA USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2797
引用
收藏
页数：1
相关论文
共 50 条
  • [41] COST OF ANTI-CD38 MONOCLONAL ANTIBODIES IN COMBINATION WITH CARFILZOMIB AND DEXAMETHASONE FOR RELAPSED REFRACTORY MULTIPLE MYELOMA
    Lin, P.
    Petitjean, A.
    Drea, E.
    Lin, F.
    VALUE IN HEALTH, 2024, 27 (06) : S148 - S148
  • [42] Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
    Lee, Hyun Tae
    Kim, Yujin
    Park, Ui Beom
    Jeong, Tae Jun
    Lee, Sang Hyung
    Heo, Yong-Seok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 536 : 26 - 31
  • [43] Critical Analysis on the Mechanism of Action (MoA) of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma (MM)
    Moreno, Laura
    Zabaleta, Aintzane
    Alignani, Diego
    Ajona, Daniel
    Lasa, Marta
    Maiso, Patricia
    Jelinek, Tomas
    Segura, Victor
    Delgado, Jose Antonio
    Rodriguez-Otero, Paula
    Prosper, Felipe
    San Miguel, Jesus
    Paiva, Bruno
    BLOOD, 2016, 128 (22)
  • [44] Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma
    Lonial, Sagar
    Bowser, Andrew D.
    Chari, Ajai
    Costello, Caitlin
    Krishnan, Amrita
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11) : 815 - 824
  • [45] Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma
    Martin, Thomas G.
    Shah, Nina
    Richter, Joshua
    Vesole, David H.
    Wong, Sandy W.
    Huang, Chiung-Yu
    Madduri, Deepu
    Jagannath, Sundar
    Siegel, David S.
    Biran, Noa
    Wolf, Jeffrey L.
    Parekh, Samir
    Cho, Hearn J.
    Munster, Pamela
    Richard, Shambavi
    Ziti-Ljajic, Samira
    Chari, Ajai
    CANCER, 2021, 127 (11) : 1816 - 1826
  • [46] Anti-CD38 monoclonal antibody impairs CD34+mobilization and affects clonogenic potential in multiple myeloma patients
    Zappaterra, Arianna
    Civettini, Ivan
    Cafro, Anna Maria
    Pezzetti, Laura
    Pierini, Silvia
    Anghilieri, Michela
    Bellio, Laura
    Bertazzoni, Paola
    Grillo, Giovanni
    Minga, Periana
    Pioltelli, Maria L.
    Ravano, Emanuele
    Sassone, Marianna
    V. Vigano, Clara
    Volpato, Elisabetta B.
    Gambacorti-Passerini, Carlo
    Rossini, Silvano
    Cairoli, Roberto
    Crocchiolo, Roberto
    BLOOD TRANSFUSION, 2024, 22 (04) : 328 - 337
  • [47] Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication
    Tai, Yu-Tzu
    de Weers, Michel
    Li, Xian-Feng
    Song, Weihua
    Nahar, Sabikun
    Bakker, Joost M.
    Vink, Tom
    Jacobs, Danielle
    Oomen, Lukas
    Bleeker, Wim K.
    Munshi, Nikhil C.
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Richardson, Paul
    Anderson, Kenneth C.
    BLOOD, 2009, 114 (22) : 252 - 252
  • [48] Preclinical development and characterization of STI-6129, an anti-CD38 antibody-drug conjugate, as a new therapeutic agent for multiple myeloma
    Li, Lingna
    Hau, Andrew
    Tong, Wenyong
    Lau, Megan
    Zhu, Tong
    Fells, Katherine
    Wei, Angel
    Li, Xiaoqing
    Deng, Dylan
    Sun, Yingqing
    Kovacs, Ernest
    Khasanov, Alisher
    Yan, Zheng
    Zhu, Panyun
    Zhou, Heyue
    Ji, Henry
    Li, Hui
    Zhang, Hong
    CANCER RESEARCH, 2020, 80 (16)
  • [49] Therapeutic potential of humanized anti-interleukin-6 receptor antibody: Antitumor activity in xenograft model of multiple myeloma
    Tsunenari, T
    Akamatsu, K
    Kaiho, SI
    Sato, K
    Tsuchiya, M
    Koishihara, Y
    Kishimoto, T
    Ohsugi, Y
    ANTICANCER RESEARCH, 1996, 16 (5A) : 2537 - 2544
  • [50] Efficacy and safety of anti-CD38 antibodies in combination with pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
    Sato, Tsuyoshi
    Asano, Kazuya
    Maeta, Takahiro
    Kiyohara, Kazuki
    Miyajima, Shinri
    Otsu, Akihiro
    Nishiya, Maki
    Sasaki, Ryousei
    Okano, Yoshiaki
    Kamihara, Satsuki
    Kowata, Shugo
    Oyake, Tatsuo
    Ito, Shigeki
    ANNALS OF ONCOLOGY, 2023, 34 : S1446 - S1446
12345